Pathogenetic mechanisms, clinical signs and consequences of the autoimmune thyroiditis impact on body systems (a literature review)

Authors

DOI:

https://doi.org/10.22141/2224-0721.18.1.2022.1147

Keywords:

autoimmune thyroiditis, influence on body systems, pathogenetic mechanisms, consequences, review

Abstract

Background. The review analyzes the publications on the pathogenetic mechanisms and clinical consequences of the impact of autoimmune thyroiditis and hypothyroidism on body systems. Autoimmune thyroiditis is an organ-specific autoimmune disease of the thyroid gland and the most common cause of hypothyroidism in regions of the world with sufficient iodine. Sources of information. The sources of information were reports in domestic and, mostly, foreign periodicals on immunology, pathological physiology, internal medicine, and endocrinology. Synthesis of evi­dence. The effect of autoimmune thyroiditis on the systems of the body is implemented in two ways. The first one is accomplished through the body’s immune system, when the organ-specific immune process in the thyroid gland for unknown reasons acquires signs of systemic disease with clinical manifestations of damage to other organs and systems. The second is due to hypothyroidism, which is the logical conclusion of the autoimmune process in the thyroid. The effects of hypothyroidism on the body as a whole and its systems, in particular, are known, and the pathogenetic mecha­nisms are not fully understood and require in-depth study. The issues of the body's autoimmune disease, the mechanisms of its initiation and progression remain undiscovered and poorly understood. Conclusions. The effect of autoimmune thyroiditis is reali­zed through the immune system when the organ-specific immune process in the thyroid gland for unknown reasons acquires signs of systemic disease and hypothyroidism, which is the logical conclusion of the autoimmune process in the thyroid gland. The pathogenetic mechanisms of the effects of autoimmune thyroiditis and hypothyroidism on the body are not fully understood and require in-depth study. The presented data show that over the last decade the interest in studying the problem of autoimmune thyroiditis, hypothyroidism, and their pathological significance for the body has deepened.

Downloads

Download data is not yet available.

References

Stathatos N, Daniels GH. Autoimmune thyroid disease. Curr Opin Rheumatol. 2012 Jan;24(1):70-5. doi: 10.1097/BOR.0b013e32834ddb27.

Ragusa F, Fallahi P, Elia G, et al. Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. doi: 10.1016/j.beem.2019.101367.

Fridkis-Hareli M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis. 2008 Feb 15;5:1. doi: 10.1186/1740-2557-5-1.

Shidlovsky VO, Shidlovsky OV, Kravtsiv VV. The effect of autoimmune thyroiditis on the organs and systems of the body (a literature review). International Journal of Endocrinology (Ukraine). 2021;17(2):145-154. doi: 10.22141/2224-0721.17.2.2021.230569. (in Ukrainian).

Department of Pathology of Johns Hopkins University. Сlassification of autoimmune diseases. Available from: https://pathology.jhu.edu/autoimmune/classification.

Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015 Jan 6;162(1):35-45. doi: 10.7326/M14-1456.

Centanni M, Marignani M, Gargano L, et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med. 1999 Aug 9-23;159(15):1726-30. doi: 10.1001/archinte.159.15.1726.

Zbigniew S. Role of Iodine in Metabolism. Recent Pat Endocr Metab Immune Drug Discov. 2017;10(2):123-126. doi: 10.2174/1872214811666170119110618.

Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015 Jun;50(6):657-67. doi: 10.3109/00365521.2015.1019918.

Lahner E, Centanni M, Agnello G, et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med. 2008 Feb;121(2):136-41. doi: 10.1016/j.amjmed.2007.09.025.

Sibilla R, Santaguida MG, Virili C, et al. Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders. Clin Endocrinol (Oxf). 2008 Apr;68(4):640-5. doi: 10.1111/j.1365-2265.2007.03091.x.

Centanni M. Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine. 2013 Feb;43(1):8-9. doi: 10.1007/s12020-012-9814-9.

Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014 Apr-May;13(4-5):459-62. doi: 10.1016/j.autrev.2014.01.048.

Ebert EC. The thyroid and the gut. J Clin Gastroenterol. 2010 Jul;44(6):402-6. doi: 10.1097/MCG.0b013e3181d6bc3e.

Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007 Nov;92(11):4180-4. doi: 10.1210/jc.2007-0606.

Lappinga PJ, Abraham SC, Murray JA, Vetter EA, Patel R, Wu TT. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med. 2010 Feb;134(2):264-70. doi: 10.5858/134.2.264.

Shidlovsky VO, Shidlovsky OV, Sheremet MI, Sydorchuk LP, Pankiv IV. Hashimoto's thyroiditis. Current Modern views on pathogenesis (literature review). International Journal of Endocrinology (Ukraine). 2020;16(4):349-354. doi: 10.22141/2224-0721.16.4.2020.208489.

Earl S. Thyroid and the Gut. Available from: https://thefatigueclinic.com/2019/10/thyroid-and-the-gut/. Accessed: 2019 Oct 21.

Motohashi N, Vadapalli J, Vanam A, Gollapudi R. The Impact of Nutrition on Hashimoto's Thyroiditis Patients: An Overview. J Clin Nutr Metab. 2018;2(2):2-6. doi: 10.4172/jcnm1000119.

Fogoros RN, Ali YS. How Does Thyroid Disease Affect the Heart? Available from: https://www.verywellhealth.com/thyroid-disease-and-the-heart-1746112. Accessed: 2020 June 2.

Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018 Apr 24;71(16):1781-1796. doi: 10.1016/j.jacc.2018.02.045.

Monzani F, Caraccio N, Kozàkowà M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004 May;89(5):2099-106. doi: 10.1210/jc.2003-031669.

Muneer R, Naqvi S, Gul O, et al. Thyroid and Heart: Severe Three Vessel Coronary Artery Disease in a Middle-Aged Female with Hypothyroidism. Cureus. 2019 Nov;11(11):e6095. doi:10.7759/cureus.6095.

Ning Y, Cheng YJ, Liu LJ, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. BMC Med. 2017 Feb 2;15(1):21. doi: 10.1186/s12916-017-0777-9.

Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010 Mar;72(3):404-10. doi: 10.1111/j.1365-2265.2009.03640.x.

Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010 Jan;95(1):186-93. doi: 10.1210/jc.2009-1625.

Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 2019 Sep 3;366:l4892. doi: 10.1136/bmj.l4892.

Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004 Jun;24(1):1-13. doi: 10.1385/ENDO:24:1:001.

Berta E, Lengyel I, Halmi S, et al. Hypertension in Thyroid Disorders. Front Endocrinol (Lausanne). 2019 Jul 17;10:482. doi: 10.3389/fendo.2019.00482.

Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S. Association between subclinical hypothyroidism and blood pressure--a meta-analysis of observational studies. Endocr Pract. 2014 Feb;20(2):150-8. doi: 10.4158/EP13237.OR.

Thompson WO, Dickie LFN, Morris AE, Hilkevitch BH. The high incidence of hypertension in toxic goiter and in myxedema. Endocrinology. 1931;15(4):265-272. doi: 10.1210/endo-15-4-265.

Stott DJ, Rodondi N, Kearney PM, et al; TRUST Study Group. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017 Jun 29;376(26):2534-2544. doi: 10.1056/NEJMoa1603825.

Colapietro N, Xodo C, Rovina M, et al. The effect of thyroid hormone normalization on ambulatory blood pressure monitoring in hypothyroid patients. J Hypertension. 2021;39(p e150). doi: 10.1097/01.hjh.0000746024.20262.f2.

Nair SN, Kumar H, Raveendran M, Menon VU. Subclinical Hypothyroidism and Cardiac Risk: Lessons from a South Indian Population Study. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):217-222. doi: 10.4103/ijem.IJEM_298_17.

Bolal M, Ates I, Demir BF, Altay M, Turhan T, Yilmaz N. The relationship between homocysteine and autoimmune subclinical hypothyroidism. Int J Med Biochem. 2020;3(1):1-7. doi:10.14744/ijmb.2019.13008.

Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007 May;92(5):1715-23. doi: 10.1210/jc.2006-1869.

He W, Li S, Zhang JA, Zhang J, Mu K, Li XM. Effect of Levothyroxine on Blood Pressure in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2018 Aug 14;9:454. doi: 10.3389/fendo.2018.00454.

Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002 Mar 19;105(11):1387-93. doi: 10.1161/hc1102.105289.

Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):55-59. doi: 10.14797/mdcj-13-2-55.

Thompson W, Russell G, Baragwanath G, Matthews J, Vaidya B, Thompson-Coon J. Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Apr;88(4):575-584. doi: 10.1111/cen.13550.

Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PLoS One. 2017 Apr 17;12(4):e0175708. doi: 10.1371/journal.pone.0175708.

Arbib N, Hadar E, Sneh-Arbib O, Chen R, Wiznitzer A, Gabbay-Benziv R. First trimester thyroid stimulating hormone as an independent risk factor for adverse pregnancy outcome. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2174-2178. doi: 10.1080/14767058.2016.1242123.

Sferruzzi-Perri AN, Vaughan OR, Forhead AJ, Fowden AL. Hormonal and nutritional drivers of intrauterine growth. Curr Opin Clin Nutr Metab Care. 2013 May;16(3):298-309. doi: 10.1097/MCO.0b013e32835e3643.

Moog NK, Entringer S, Heim C, Wadhwa PD, Kathmann N, Buss C. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017 Feb 7;342:68-100. doi: 10.1016/j.neuroscience.2015.09.070.

Dickens LT, Cifu AS, Cohen RN. Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Period. JAMA. 2019 May 21;321(19):1928-1929. doi: 10.1001/jama.2019.5321.

Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar TIM, Derakhshan A, Taylor PN, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. JAMA. 2019 Aug 20;322(7):632-641. doi: 10.1001/jama.2019.10931.

Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457.

Rao M, Zeng Z, Zhou F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Hum Reprod Update. 2019 May 1;25(3):344-361. doi: 10.1093/humupd/dmz003.

Ju R, Lin L, Long Y, Zhang J, Huang J. Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy. Genet Mol Res. 2016 Nov 21;15(4). doi: 10.4238/gmr15049019.

Zhao L, Jiang G, Tian X, et al. Initiation timing effect of levothyroxine treatment on subclinical hypothyroidism in pregnancy. Gynecol Endocrinol. 2018 Oct;34(10):845-848. doi: 10.1080/09513590.2018.1451836.

Giuffrida G, Bagnato G, Campennì A, et al. Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study. J Endocrinol Invest. 2020 Jan;43(1):87-94. doi: 10.1007/s40618-019-01083-w.

Ruggeri RM, Trimarchi F, Giuffrida G, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017 Feb;176(2):133-141. doi: 10.1530/EJE-16-0737.

Nazary K, Hussain N, Ojo RO, et al. Prevalence of Thyroid Dysfunction in Newly Diagnosed Rheumatoid Arthritis Patients. Cureus. 2021 Sep 23;13(9):e18204. doi: 10.7759/cureus.18204.

Bland JH, Frymoyer JW, Newberg AH, Revers R, Norman RJ. Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum. 1979 Aug;9(1):23-65. doi: 10.1016/0049-0172(79)90002-7.

Tagoe CE. Rheumatic symptoms in autoimmune thyroiditis. Curr Rheumatol Rep. 2015 Feb;17(2):5. doi: 10.1007/s11926-014-0479-7.

Elattar EA, Younes TB, Mobasher SA. Hypothyroidism in patients with rheumatoid arthritis and its relation to disease activity. Egypt Rheumatol Rehabil. 2014;41(2):58-65. doi: 10.4103/1110-161X.132458.

Ortega-Hernandez OD, Pineda-Tamayo R, Pardo AL, Rojas-Villarraga A, Anaya JM. Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin Rheumatol. 2009 Jul;28(7):767-75. doi: 10.1007/s10067-009-1145-8.

Haliloglu S, Ekinci B, Uzkeser H, Sevimli H, Carlioglu A, Macit PM. Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity. Clin Rheumatol. 2017 Jul;36(7):1617-1621. doi: 10.1007/s10067-017-3556-2.

Galvez-Sánchez CM, Reyes Del Paso GA. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives. J Clin Med. 2020 Apr 23;9(4):1219. doi: 10.3390/jcm9041219.

Churilov LP, Sobolevskaia PA, Stroev YI. Thyroid gland and brain: Enigma of Hashimoto's encephalopathy. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101364. doi: 10.1016/j.beem.2019.101364.

Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi:10.1016/S1474-4422(15)00401-9.

Philip R, Saran S, Gutch M, Gupta K. An unusual presentation of Hashimoto's encephalopathy. Indian J Endocrinol Metab. 2014 Jan;18(1):113-5. doi: 10.4103/2230-8210.126589.

Rocchi R, Rose NR, Caturegli P. Hahimoto Thyroiditis. In: Shoenfeld Y, Cervera R, Gershwin ME, editors. Diagnostic Criteria in Autoimmune Diseases. Humana Press; 2008. pp 217-220. doi: 10.1007/978-1-60327-285-8_41.

Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012 Mar;96(2):203-21. doi: 10.1016/j.mcna.2012.01.005.

Petnehazy E, Buchinger W. [Hashimoto thyroiditis, therapeutic options and extrathyroidal options - an up-to-date overview]. Wien Med Wochenschr. 2020 Feb;170(1-2):26-34. German. doi: 10.1007/s10354-019-0691-1.

Djurovic M, Pereira AM, Smit JWA, et al. Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement. Endocrine. 2018 Oct;62(1):136-143. doi: 10.1007/s12020-018-1649-6.

Correia I, Marques IB, Ferreira R, Sousa L. Encephalopathy Associated with Autoimmune Thyroid Disease: A Potentially Reversible Condition. Case Rep Med. 2016;2016:9183979. doi: 10.1155/2016/9183979.

Lalanne L, Meriot ME, Ruppert E, Zimmermann MA, Danion JM, Vidailhet P. Attempted infanticide and suicide inaugurating catatonia associated with Hashimoto's encephalopathy: a case report. BMC Psychiatry. 2016 Jan 19;16:13. doi: 10.1186/s12888-016-0719-7.

Philip R, Saran S, Gutch M, Gupta K. An unusual presentation of Hashimoto's encephalopathy. Indian J Endocrinol Metab. 2014 Jan;18(1):113-5. doi: 10.4103/2230-8210.126589.

Fiore AA, Pfeiffer WB, Rizvi SAA, et al. Hashimoto Encephalopathy as a Complication of Autoimmune Thyroiditis. Med Princ Pract. 2019;28(1):91-95. doi: 10.1159/000494800.

Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb;63(2):197-202. doi: 10.1001/archneur.63.2.197.

Yalcin MM, Altinova AE, Cavnar B, et al. Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto's thyroiditis? Endocr J. 2017 Apr 29;64(4):425-429. doi: 10.1507/endocrj.EJ16-0418.

Giynas Ayhan M, Uguz F, Askin R, Gonen MS. The prevalence of depression and anxiety disorders in patients with euthyroid Hashimoto's thyroiditis: a comparative study. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):95-8. doi: 10.1016/j.genhosppsych.2013.10.002.

Flanagan EP, Caselli RJ. Autoimmune encephalopathy. Semin Neurol. 2011 Apr;31(2):144-57. doi: 10.1055/s-0031-1277985.

Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999 Oct 22;53(7):1579-81. doi: 10.1212/wnl.53.7.1579.

Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997 Aug;49(2):623-6. doi: 10.1212/wnl.49.2.623.

Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003 Feb;60(2):164-71. doi: 10.1001/archneur.60.2.164.

Tang Y, Xing Y, Lin MT, Zhang J, Jia J. Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol. 2012 Jul 24;12:60. doi: 10.1186/1471-2377-12-60.

Laurent C, Capron J, Quillerou B, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev. 2016 Dec;15(12):1129-1133. doi: 10.1016/j.autrev.2016.09.008.

Sharma PM, Javali M, Mahale R, Madhusudhan BK, Majeed AA, Srinivasa R. Hashimoto encephalopathy: A study of the clinical profile, radiological and electrophysiological correlation in a Tertiary Care Center in South India. J Neurosci Rural Pract. 2015 Jul-Sep;6(3):309-14. doi: 10.4103/0976-3147.158753.

Payer J, Petrovic T, Lisy L, Langer P. Hashimoto encephalopathy: a rare intricate syndrome. Int J Endocrinol Metab. 2012 Spring;10(2):506-14. doi: 10.5812/ijem.4174.

Lu T, Zhou Z, Wu A, Qin B, Lu Z. Febrile Hashimoto's encephalopathy associated with Hashitoxicosis. Acta Neurol Belg. 2015 Dec;115(4):811-3. doi: 10.1007/s13760-015-0451-y.

Alazzeh A, Jaroudi S, Gooch M, Peiris AN. Focal neurological presentation in Hashimoto's encephalopathy mimicking a vascular occlusion of the middle cerebral artery. BMJ Case Rep. 2017 Jul 14;2017:bcr2017219933. doi: 10.1136/bcr-2017-219933.

Santoro D, Vadalà C, Siligato R, Buemi M, Benvenga S. Autoimmune Thyroiditis and Glomerulopathies. Front Endocrinol (Lausanne). 2017 Jun 2;8:119. doi: 10.3389/fendo.2017.00119.

Ronco P, Debiec H. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients. Mol Immunol. 2015 Nov;68(1):57-62. doi: 10.1016/j.molimm.2015.07.003.

Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol. 2011 Jul 19;7(12):697-705. doi: 10.1038/nrneph.2011.89.

Holdsworth SR, Gan PY, Kitching AR. Biologics for the treatment of autoimmune renal diseases. Nat Rev Nephrol. 2016 Apr;12(4):217-31. doi: 10.1038/nrneph.2016.18.

Liu W, Gao C, Dai H, et al. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role. Front Immunol. 2019 Aug 6;10:1809. doi: 10.3389/fimmu.2019.01809.

Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab Disord. 2017 Mar;18(1):131-144. doi: 10.1007/s11154-016-9395-7.

Zhao L, Liu Y, Su H, Shi X. Relationship between autoimmune thyroid disease and nephropathy: A clinicopathological study. Medicine (Baltimore). 2021 Jun 11;100(23):e26273. doi: 10.1097/MD.0000000000026273.

Sorensen JR, Winther KH, Bonnema SJ, Godballe C, Hegedüs L. Respiratory Manifestations of Hypothyroidism: A Systematic Review. Thyroid. 2016 Nov;26(11):1519-1527. doi: 10.1089/thy.2015.0642.

Sadek SH, Khalifa WA, Azoz AM. Pulmonary consequences of hypothyroidism. Ann Thorac Med. 2017 Jul-Sep;12(3):204-208. doi: 10.4103/atm.ATM_364_16.

McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011 Aug;21(8):837-43. doi: 10.1089/thy.2010.0298.

Sadek SH, Khalifa WA, Azoz AM. Pulmonary consequences of hypothyroidism. Ann Thorac Med. 2017 Jul-Sep;12(3):204-208. doi: 10.4103/atm.ATM_364_16.

Palaparthi SKC, Suresh V, Mohan A, Sachan A. Respiratory dysfunction in hypothyroidism. J Clin Sci Res. 2019;8(2):89-94. doi:10.4103/jcsr.jcsr_54_19.

Published

2022-06-29

How to Cite

Shidlovskyy, O., Shidlovskyy, V., Sheremet, M., Pankiv, I., Kravtsiv, V., Lazaruk, A., & Golovatyi, V. (2022). Pathogenetic mechanisms, clinical signs and consequences of the autoimmune thyroiditis impact on body systems (a literature review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 18(1), 70–77. https://doi.org/10.22141/2224-0721.18.1.2022.1147

Issue

Section

Literature Review

Most read articles by the same author(s)

1 2 3 4 > >>